EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Herpes Zoster Vaccine Uptake Among United States Adults With Rheumatic Disease: A Mixed‐Methods Analysis

Justin Carrico, Catherine McGuiness, Marie Yasuda, Chi-Chang Chen, Vasudha Gupta, Rita Campos, Nikita Stempniewicz, Justin Gatwood iD

ACR Open Rheumatology · 2026-03 · 8 (3)

DOI: 10.1002/acr2.90012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACR Open Rheumatology, online erschienen am 23.03.2026. Verfasst von Justin Carrico und 7 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Philadelphia, Pennsylvania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GSK.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Adults with rheumatic diseases are at increased risk for herpes zoster (HZ). Recommendations for the recombinant zoster vaccine (RZV) were expanded in 2021 to include those aged ≥19 years at increased risk for HZ due to immunodeficiency or immunosuppression because of disease or therapy, but the impact of these expanded recommendations is unclear. This study assessed the impact of the updated recommendations on RZV uptake among adults with rheumatic disease in the US.

Methods

A retrospective cohort analysis used open‐source claims data to estimate RZV uptake, series completion, and dosing schedule compliance among unvaccinated adults with rheumatic disease from October 2021 to June 2023. Interviews with rheumatologists were conducted and thematically analyzed to characterize RZV vaccination practices related to managing patients with rheumatic disease.

Results

RZV uptake among adults with rheumatic disease and without prior RZV over the 20‐month period following the updated recommendations was gradual (7.0%–10.4% across conditions) and low, and was particularly less likely among adults

Autor:innen und Institutionen

  • GSK, Philadelphia, Pennsylvania.
  • IQVIA, Wayne, Pennsylvania.

ORCID-Profile: Justin Gatwood

Förderung

  • GSK

Zitieren

APA

Carrico, J., McGuiness, C., Yasuda, M., Chen, C. C., Gupta, V., Campos, R., Stempniewicz, N., & Gatwood, J. (2026). Herpes Zoster Vaccine Uptake Among United States Adults With Rheumatic Disease: A Mixed‐Methods Analysis. ACR Open Rheumatology, 8(3). https://doi.org/10.1002/acr2.90012

Vancouver

Carrico J, McGuiness C, Yasuda M, Chen CC, Gupta V, Campos R, et al. Herpes Zoster Vaccine Uptake Among United States Adults With Rheumatic Disease: A Mixed‐Methods Analysis. ACR Open Rheumatology. 2026;8(3). doi:10.1002/acr2.90012

BibTeX
@article{Carrico2026,
  author = {Carrico, Justin and McGuiness, Catherine and Yasuda, Marie and Chen, Chi-Chang and Gupta, Vasudha and Campos, Rita and Stempniewicz, Nikita and Gatwood, Justin},
  title = {Herpes Zoster Vaccine Uptake Among United States Adults With Rheumatic Disease: A Mixed‐Methods Analysis},
  journal = {ACR Open Rheumatology},
  year = {2026},
  volume = {8},
  number = {3},
  doi = {10.1002/acr2.90012}
}
Kostenlos starten →